{"cdcTestId":"2013-0257","testcaseName":"dose 1 to 2 Pediarix, interval 28-4 days","vaccineGroup":"HepB","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-07-25T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2023-01-15T00:00:00","recommendedDate":"2023-01-25T00:00:00","pastDueDate":"2024-03-23T00:00:00"},"doses":[{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T08:14:27.988","generalDescription":"This test case describes when dose #2 of the HepB vaccine is administered at an interval of 28 - 4 days that the dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}